Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Shc2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SHC2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Shc2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SHC2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SHC2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SHC2 mRNA | CTD | PMID:34747641 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:32119087 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Shc2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SHC2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Shc2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of SHC2 promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Shc2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of SHC2 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SHC2 mRNA | CTD | PMID:36041667 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SHC2 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SHC2 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of SHC2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | SHC2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SHC2 gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SHC2 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of SHC2 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | SHC2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SHC2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | SHC2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SHC2 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases methylation | ISO | SHC2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SHC2 exon and Benzo(a)pyrene results in increased methylation of SHC2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SHC2 mRNA | CTD | PMID:32234424 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SHC2 promoter and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:23359474 and PMID:31199487 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SHC2 mRNA and [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SHC2 promoter | CTD | PMID:23359474 and PMID:36041667 | bisphenol A | multiple interactions | ISO | SHC2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SHC2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SHC2 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SHC2 mRNA | CTD | PMID:36041667 | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:31199487 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of SHC2 promoter | CTD | PMID:22457795 | calcitriol | multiple interactions | ISO | SHC2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SHC2 mRNA | CTD | PMID:21592394 | calcitriol | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SHC2 mRNA | CTD | PMID:21592394 | choline | multiple interactions | ISO | Shc2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHC2 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SHC2 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | SHC2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SHC2 mRNA | CTD | PMID:27392435 | cyclosporin A | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SHC2 mRNA | CTD | PMID:25562108 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SHC2 promoter and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:23359474 and PMID:31199487 | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:31199487 | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:31199487 | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA | CTD | PMID:31199487 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SHC2 mRNA | CTD | PMID:29391264 | ethanol | affects splicing | ISO | Shc2 (Mus musculus) | 6480464 | Ethanol affects the splicing of SHC2 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Shc2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHC2 mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | SHC2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SHC2 gene | CTD | PMID:31601247 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of SHC2 mRNA | CTD | PMID:27387713 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SHC2 mRNA | CTD | PMID:22061828 and PMID:33387578 | L-methionine | multiple interactions | ISO | Shc2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SHC2 mRNA | CTD | PMID:20938992 | lead(0) | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Lead results in increased expression of SHC2 mRNA | CTD | PMID:19921347 | Monobutylphthalate | increases expression | ISO | Shc2 (Mus musculus) | 6480464 | monobutyl phthalate results in increased expression of SHC2 mRNA | CTD | PMID:35278568 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SHC2 mRNA | CTD | PMID:28801915 | paracetamol | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SHC2 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SHC2 mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | increases expression | ISO | Shc2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SHC2 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Shc2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SHC2 mRNA | CTD | PMID:36331819 | silicon dioxide | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of SHC2 mRNA | CTD | PMID:25895662 | sodium arsenite | affects methylation | ISO | SHC2 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of SHC2 gene | CTD | PMID:28589171 | sodium arsenite | decreases expression | ISO | Shc2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SHC2 mRNA | CTD | PMID:37682722 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SHC2 mRNA | CTD | PMID:35314868 | testosterone | increases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of SHC2 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | SHC2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SHC2 mRNA | CTD | PMID:21592394 | valproic acid | increases methylation | ISO | SHC2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SHC2 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | SHC2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SHC2 mRNA | CTD | PMID:26272509 and PMID:29154799 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of SHC2 gene | CTD | PMID:31079544 | |